Enterprise Value

330.9M

Cash

505.9M

Avg Qtr Burn

-163.5M

Short % of Float

52.96%

Insider Ownership

0.60%

Institutional Own.

70.61%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Update

Approved

Update

Phase 3

Data readout

Phase 3

Data readout

Phase 2

Initiation

RSV Vaccine Details
Respiratory syncytial virus

Failed

Discontinued

RSV Vaccine Details
Respiratory syncytial virus

Failed

Discontinued

RSV Vaccine Details
Respiratory syncytial virus

Failed

Discontinued